Impact of decreasing copayments on medication adherence within a disease management environment
Department of Quantitative Health Sciences
Adult; Aged; Anticholesteremic Agents; Cohort Studies; *Cost Sharing; Cross-Sectional Studies; Databases, Factual; *Disease Management; Female; Health Benefit Plans, Employee; Humans; Male; Middle Aged; Patient Compliance; United States
Biostatistics | Epidemiology | Health Services Research
This paper estimates the effects of a large employer's value-based insurance initiative designed to improve adherence to recommended treatment regimens. The intervention reduced copayments for five chronic medication classes in the context of a disease management (DM) program. Compared to a control employer that used the same DM program, adherence to medications in the value-based intervention increased for four of five medication classes, reducing nonadherence by 7-14 percent. The results demonstrate the potential for copayment reductions for highly valued services to increase medication adherence above the effects of existing DM programs.
Rights and Permissions
Citation: Health Aff (Millwood). 2008 Jan-Feb;27(1):103-12. Link to article on publisher's site
Health affairs (Project Hope)
Chernew, Michael E.; Shah, Mayur R.; Wegh, Arnold; Rosenberg, Stephen N.; Juster, Iver A.; Rosen, Allison B.; Sokol, Michael C.; Yu-Isenberg, Kristina; and Fendrick, A. Mark, "Impact of decreasing copayments on medication adherence within a disease management environment" (2008). Quantitative Health Sciences Publications and Presentations. 926.